Moderna COVID-19 vaccine (redirect from Spikevax)
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
165 KB (13,038 words) - 22:10, 17 July 2024
company's only commercial product is the Moderna COVID-19 vaccine, marketed as Spikevax. The company has 45 treatment and vaccine candidates, of which 38 have...
25 KB (1,991 words) - 14:30, 1 July 2024
2020. "EMA recommends standard marketing authorizations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency. 16 September 2022. Archived...
199 KB (22,726 words) - 08:47, 6 August 2024
which the first authorized were COVID-19 vaccines (such as Comirnaty and Spikevax). mRNA is produced by synthesising a ribonucleic acid (RNA) strand from...
24 KB (2,503 words) - 11:29, 22 February 2024
Turkey[unreliable source?] The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S....
319 KB (19,375 words) - 22:21, 17 July 2024
with Moderna for fill-finish, packaging and labeling of its mRNA vaccine, Spikevax. The company was also contracted to manufacture Eli Lilly's COVID-19 antibody...
16 KB (1,268 words) - 17:57, 13 August 2024
world. Brand Institute also developed the COVID-19 vaccine brand names Spikevax (Moderna), Vaxzevria (AstraZeneca), and Nuvaxovid (Novavax). Other brands...
10 KB (855 words) - 14:53, 22 July 2024
infection effectiveness Hospitalization effectiveness Mortality effectiveness Spikevax 91.45% 78% 93.46% Comirnaty 80.34% 84.26% 89.83% Sputnik V 78.75% 81.38%...
154 KB (13,880 words) - 03:06, 18 August 2024
2022. "Myokarditt hos gutter og unge menn kan forekomme oftere etter Spikevax-vaksinen fra Moderna". October 6, 2021. Archived from the original on January...
7 KB (541 words) - 20:34, 16 May 2024
States National Institute of Allergy and Infectious Diseases and Moderna (Spikevax) have been rolled out. As of 13 September 2021[update], there were four...
118 KB (9,094 words) - 03:07, 15 June 2024
2022. "EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines". European Medicines Agency (EMA) (Press release). 16...
250 KB (21,490 words) - 17:55, 3 August 2024
mRNA-1283 Vaccine description Target SARS-CoV-2 Vaccine type mRNA Clinical data Trade names Spikevax Routes of administration Intramuscular...
5 KB (387 words) - 20:39, 30 May 2024
States National Institute of Allergy and Infectious Diseases and Moderna (Spikevax) have been rolled out. As of 13 September 2021[update], there were four...
235 KB (22,889 words) - 14:42, 19 August 2024
vaccine Coronavirus RNA COVID-19 Comirnaty Convidecia CoronaVac Covaxin Spikevax Covishield CoviVac Covovax EpiVacCorona Janssen COVID-19 vaccine RBD-Dimer...
34 KB (2,305 words) - 03:06, 24 December 2023
dead link] "TGA approves booster doses of the Moderna COVID-19 vaccine, SPIKEVAX". 8 December 2021. Archived from the original on 31 December 2021. Retrieved...
178 KB (12,119 words) - 06:32, 23 May 2024
2021 25 Jun 2021 5 Apr 2022 CoronaVac 104 million $11.60 17 Jan 2021 17 Jan 2021 Pending Spikevax (Moderna) 0 Unknown Skipped 15 May 2024 26 Jun 2023...
118 KB (9,249 words) - 18:41, 22 May 2024
announced that it would bring forward the rollout of the bivalent Moderna/Spikevax COVID-19 vaccine three days to 14 October, due to the spike in infections...
62 KB (2,614 words) - 13:21, 20 June 2024
arrived in Bulgaria, with 290,880 Comirnaty Original/Omicron BA.1 and 1800 Spikevax Bivalent Original/Omicron BA.1 being delivered. Moderna's vaccine for the...
453 KB (34,260 words) - 15:07, 13 June 2024
Sweden phase III clinical trials 18 March 2021 22 March 2021 Moderna Spikevax Moderna United States phase III clinical trials 5 May 2021 9 June 2021...
76 KB (6,546 words) - 20:42, 16 May 2024
July 16, 2022. Retrieved July 16, 2022. "Regulatory Decision Summary - Spikevax - Health Canada". Health Canada. Archived from the original on July 16...
185 KB (14,787 words) - 04:28, 26 July 2024
Retrieved 14 April 2022. "MHRA approves the Moderna COVID-19 vaccine 'Spikevax' for use in 6 to 11-year olds". Gov.uk. 14 April 2022. Retrieved 14 April...
275 KB (30,530 words) - 03:40, 31 July 2024
Retrieved 14 April 2022. "MHRA approves the Moderna COVID-19 vaccine 'Spikevax' for use in 6 to 11-year olds". Gov.uk. 14 April 2022. Retrieved 14 April...
177 KB (21,504 words) - 17:59, 4 July 2024
COVID-19 vaccine for youngest kids". CBC News. "Regulatory Decision Summary - Spikevax - Health Canada". Health Canada. Archived from the original on 2022-07-16...
150 KB (8,492 words) - 21:35, 4 August 2024
approval granted 2019). mRNA vaccines: Moderna COVID-19 Vaccine (branded as Spikevax) designed to provide protection against COVID-19 caused by infection with...
78 KB (8,788 words) - 19:06, 6 August 2024